文献速递血栓与止血

斑马鱼血小板生成素缺陷性血小板减少模型的建立

Generation of a thrombopoietin-deficient thrombocytopenia model in zebrafish.
PubMed 文献 · J Thromb Haemost · 2022-06-15

研究利用CRISPR/Cas9技术构建斑马鱼thpo功能缺失模型,thposzy6突变体thpo表达显著降低并出现血小板减少。该模型可用于研究人THPO变异及评估血小板生成素受体激动剂的效果。

要点

  • CRISPR/Cas9构建的thposzy6斑马鱼thpo表达显著降低并出现血小板减少。
  • 该模型可研究人THPO临床变异(c.091C>T和c.112C>T)导致的血小板减少表型。
  • 该模型可用于评估血小板生成素受体激动剂对血小板减少的疗效。

核心结论

  • thposzy6突变斑马鱼thpo表达显著降低并出现血小板减少。
  • Thpo功能缺失斑马鱼模型可作为thpo缺陷所致血小板减少的临床前模型,并用于研究人THPO变异和评估THPO-RAs效果。

研究设计与样本

  • 利用CRISPR/Cas9技术构建斑马鱼thpo功能缺失模型。
  • 在thposzy6突变斑马鱼中进行体内研究,并评估THPO-RAs在Tg(mpl:eGFP);thposzy6品系中的效果。

主要发现

  • thposzy6斑马鱼thpo表达显著降低并出现血小板减少。
  • 发现两个人临床点突变(c.091C>T和c.112C>T)导致血小板减少表型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The production of platelets is tightly regulated by thrombopoietin (THPO). Mutations in the THPO gene cause thrombocytopenia. Although mice lacking Thpo present with thrombocytopenia, predicting phenotypes and pathogenicity of novel THPO mutations in mice is limited. Zebrafish can be a powerful tool for fast validation and study of candidate genes of human hematological diseases and have already been used as a model of human thrombocytopenia. OBJECTIVES: We aim to investigate the role of Thpo in zebrafish thrombopoiesis and to establish a Thpo-deficient zebrafish model. The model could be applied for illustrating the clinically discovered human THPO variants of which the clinical significance is not known and to evaluate the effect of THPO receptor agonists (THPO-Ras), as well as a screening platform for new drugs. METHODS: We generated a thpo loss-of-function zebrafish model using CRISPR/Cas9. After disruption of zebrafish thpo, thposzy6 zebrafish presented with a significant reduction of thpo expression and developed thrombocytopenia. Furthermore, we performed in vivo studies with zebrafish with the thposzy6 mutation and found two human clinical point mutations (c.091C > T and c.112C > T) that were responsible for the thrombocytopenia phenotype. In addition, effects of THPO-RAs used as therapeutics against thrombocytopenia were evaluated in the Tg(mpl:eGFP);thposzy6 line. RESULTS AND CONCLUSIONS: Zebrafish with the mutation thposzy6 presented with a significant reduction of thpo expression and developed thrombocytopenia. Thpo loss-of-function zebrafish model can serve as a valuable preclinical model for thrombocytopenia caused by thpo-deficiency, as well as a tool to study human clinical THPO variants and evaluate the effect of THPO-RAs.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Yang L, Wu L, Meng P, et al. Generation of a thrombopoietin-deficient thrombocytopenia model in zebrafish. J Thromb Haemost. 2022. PMID: 35622056. doi:10.1111/jth.15772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。